Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Nature Chemical Biology|March 29, 2016
Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identificationRichard M Deans, David W Morgens, Ayşe Ökesli, et al.Nature Communications|October 28, 2022
The N6-methyladenosine methyltransferase METTL16 enables erythropoiesis through safeguarding genome integrityMasanori Yoshinaga, Kyuho Han, David W Morgens, et al.Nature|October 2, 2024
CRISPR-Cas9 screens reveal regulators of ageing in neural stem cellsTyson J Ruetz, Angela N Pogson, Chloe M Kashiwagi, et al.Nature Genetics|March 7, 2018
CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicityNicholas J Kramer, Michael S Haney, David W Morgens, et al.Nature Communications|May 6, 2017
Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screensDavid W Morgens, Michael Wainberg, Evan A Boyle, et al.Developmental Cell|July 26, 2023
Parallel CRISPR-Cas9 screens identify mechanisms of PLIN2 and lipid droplet regulationMelissa A Roberts, Kirandeep K Deol, Alyssa J Mathiowetz, et al.Nature Neuroscience|February 2, 2020
Author Correction: Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brainJulia Marschallinger, Tal Iram, Macy Zardeneta, et al.Nature Neuroscience|July 29, 2020
Author Correction: Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brainJulia Marschallinger, Tal Iram, Macy Zardeneta, et al.Nature Neuroscience|January 22, 2020
Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brainJulia Marschallinger, Tal Iram, Macy Zardeneta, et al.Cancer Research|September 29, 2018
CBP Modulates Sensitivity to Dasatinib in Pre-BCR+ Acute Lymphoblastic LeukemiaJesús Duque-Afonso, Chiou-Hong Lin, Kyuho Han, et al.Pageof 5